Found: 40
Select item for more details and to access through your institution.
Influenza Vaccine Hesitancy in Patients with Multiple Sclerosis: A Monocentric Observational Study.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 7, p. 890, doi. 10.3390/brainsci11070890
- By:
- Publication type:
- Article
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 14, p. 2243, doi. 10.1177/13524585221114007
- By:
- Publication type:
- Article
Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 93, doi. 10.1177/13524585211005657
- By:
- Publication type:
- Article
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 3, p. 430, doi. 10.1177/1352458520974366
- By:
- Publication type:
- Article
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 5, p. 659, doi. 10.1177/1352458515599075
- By:
- Publication type:
- Article
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis.
- Published in:
- Annals of Neurology, 2022, v. 91, n. 4, p. 483, doi. 10.1002/ana.26322
- By:
- Publication type:
- Article
Epigenetics: An opportunity to shape innate and adaptive immune responses.
- Published in:
- Immunology, 2022, v. 167, n. 4, p. 451, doi. 10.1111/imm.13571
- By:
- Publication type:
- Article
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 8, p. 5074, doi. 10.1007/s00415-024-12448-4
- By:
- Publication type:
- Article
Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 3, p. 1150, doi. 10.1007/s00415-023-12137-8
- By:
- Publication type:
- Article
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 1, p. 24, doi. 10.1007/s00415-023-12034-0
- By:
- Publication type:
- Article
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 6, p. 3301, doi. 10.1007/s00415-022-11009-x
- By:
- Publication type:
- Article
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 2, p. 933, doi. 10.1007/s00415-021-10676-6
- By:
- Publication type:
- Article
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 10, p. 2440, doi. 10.1007/s00415-019-09424-8
- By:
- Publication type:
- Article
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 5, p. 1174, doi. 10.1007/s00415-018-8831-x
- By:
- Publication type:
- Article
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspective.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 1, p. 45, doi. 10.1007/s10072-022-06402-3
- By:
- Publication type:
- Article
GAD65 autoimmunity after treatment with nivolumab: a multifocal presentation.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 10, p. 4289, doi. 10.1007/s10072-021-05312-0
- By:
- Publication type:
- Article
Anti-MOG-associated demyelinating disorders: two sides of the same coin.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 4, p. 1531, doi. 10.1007/s10072-020-04892-7
- By:
- Publication type:
- Article
One year experience with erenumab: real-life data in 30 consecutive patients.
- Published in:
- Neurological Sciences, 2020, v. 41, p. 505, doi. 10.1007/s10072-020-04677-y
- By:
- Publication type:
- Article
Visual hallucinations as psychiatric onset of a primary central nervous system lymphoma: a case report and a brief review of literature on neoplasm-correlated neuropsychiatric disorders.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants.
- Published in:
- Nature Immunology, 2015, v. 16, n. 11, p. 1174, doi. 10.1038/ni.3269
- By:
- Publication type:
- Article
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211019574
- By:
- Publication type:
- Article
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211019574
- By:
- Publication type:
- Article
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0180651
- By:
- Publication type:
- Article
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study.
- Published in:
- Neurology & Therapy, 2022, v. 11, n. 3, p. 1193, doi. 10.1007/s40120-022-00364-6
- By:
- Publication type:
- Article
Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1383910
- By:
- Publication type:
- Article
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1386527
- By:
- Publication type:
- Article
Investigating the association between neoplasms and MOG antibody-associated disease.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1193211
- By:
- Publication type:
- Article
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4236, doi. 10.3390/jcm12134236
- By:
- Publication type:
- Article
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 22, p. 6855, doi. 10.3390/jcm11226855
- By:
- Publication type:
- Article
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 8, p. 2081, doi. 10.3390/jcm11082081
- By:
- Publication type:
- Article
Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2019.03136
- By:
- Publication type:
- Article
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 11, p. 1566, doi. 10.3390/ph16111566
- By:
- Publication type:
- Article
Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 8, p. 1071, doi. 10.3390/ph16081071
- By:
- Publication type:
- Article
Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 12, p. 466, doi. 10.3390/ph13120466
- By:
- Publication type:
- Article
A score that predicts aquaporin‐4 IgG positivity in patients with longitudinally extensive transverse myelitis.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 8, p. 2534, doi. 10.1111/ene.15863
- By:
- Publication type:
- Article
A real‐world study of alemtuzumab in a cohort of Italian patients.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 1, p. 257, doi. 10.1111/ene.15121
- By:
- Publication type:
- Article